Kasch, Silja and Dowling, Michael (2008) Commercialization strategies of young biotechnology firms: An empirical analysis of the US industry. RESEARCH POLICY, 37 (10). pp. 1765-1777. ISSN 0048-7333, 1873-7625
Full text not available from this repository. (Request a copy)Abstract
We studied the commercialization strategies of young biotechnology companies in the United States building on previous studies by assuming that commercialization also includes intermediate forms like hierarchical or bilateral cooperation. Our hypotheses are derived from the Resource-Based View, Transaction Cost Economics, and Property Rights Theory. The results show that the propensity to integrate is related to the appropriability regime, direct capabilities, financial resources, and synergies between the products. Our results show that the Resource-Based View and Property Rights Theory contribute a great deal to explaining commercialization strategies, whereas Transaction Cost Economics explains less. (C) 2008 Elsevier B.V. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | TRANSACTION COST APPROACH; RESOURCE-BASED VIEW; VERTICAL INTEGRATION; TECHNOLOGICAL INNOVATION; ALLIANCE FORMATION; CAPABILITIES; DECISIONS; GOVERNANCE; SUCCESS; ORGANIZATION; Biotechnology; Commercialization; Resources; Transaction costs |
| Subjects: | 300 Social sciences > 330 Economics |
| Divisions: | Business, Economics and Information Systems > Institut für Betriebswirtschaftslehre > Lehrstuhl für Innovations- und Technologiemanagement (Prof. Dr. Michael Dowling) |
| Depositing User: | Petra Gürster |
| Date Deposited: | 09 Aug 2022 08:51 |
| Last Modified: | 09 Aug 2022 08:51 |
| URI: | https://pred.uni-regensburg.de/id/eprint/30019 |
Actions (login required)
 |
View Item |
